Name: Can-Fite BioPharma
Address: 10 Bareket Street, Petah-Tikva, 49170, ISRAEL
Telephone: +972-3-9241114

Date	Form	Description	Pages
04/14/25	20-F	Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Documents expand_more EX-1.1 EX-2.1 EX-4.10 EX-11.1 EX-12.1 EX-13.1 EX-15.1	155
03/28/24	20-F	Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) Documents expand_more EX-2.1 EX-4.9 EX-12.1 EX-13.1 EX-15.1 EX-97.1	135
03/30/23	20-F	Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) Documents expand_more EX-1.1 EX-12.1 EX-12.2 EX-13.1 EX-13.2 EX-15.1	135
03/24/22	20-F	Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) Documents expand_more EX-8.1 EX-12.1 EX-12.2 EX-13.1 EX-13.2 EX-15.1	109
03/25/21	20-F	Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) Documents expand_more EX-12.1 EX-12.2 EX-13.1 EX-13.2 EX-15.1	179
03/27/20	20-F	Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) Documents expand_more EX-2.1 EX-4.23 EX-12.1 EX-12.2 EX-13.1 EX-13.2 EX-15.1	212
04/02/19	20-F/A	Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) Documents expand_more EX-12.1 EX-12.2 EX-13.1 EX-13.2 EX-15.1	193
03/29/19	20-F	Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) Documents expand_more EX-12.1 EX-12.2 EX-13.1 EX-13.2 EX-15.1	192
03/28/18	20-F	Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) Documents expand_more EX-8.1 EX-12.1 EX-12.2 EX-13.1 EX-13.2 EX-15.1	183
03/30/17	20-F	Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) Documents expand_more EX-4.31 EX-8.1 EX-12.1 EX-12.2 EX-13.1 EX-13.2 EX-15.1	234

rss_feed Filing RSS

Upon receiving a request from any shareholder of Can-Fite BioPharma Ltd. who wishes to receive a hard copy of the Company’s complete audited financial statements, the Company will furnish such audited financial statements free of charge. Such request may either be directed to Can-Fite BioPharma Ltd., 26 Ben Gurion Street, Ramat Gan 5257346 Israel, Attn: Chief Financial Officer or to info@canfite.com.